Loteprednol/tobramycin, sold under the brand name Zylet, is a fixed-dose combination medication used for the treatment of inflammation of the eye. It is a combination of loteprednol, as the etabonate, a corticosteroid; and tobramycin, an aminoglycoside antibiotic. It is used as drops in the eye.
Loteprednol/tobramycin was approved for medical use in the United States in December 2004.
References
Further reading